ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Luoxin Pharmacy to Develop Narrow-Spectrum Antibiotic
publication date: Jun 13, 2011
Shandong Luoxin Pharmacy Stock Co. announced it would begin developing cefazedone sodium and cefazedone sodium for injection. Cefazedone is a narrow spectrum antibiotic that is used to treat enterococci, a gram-positive cocci that occurs in the digestive tract. Luoxin says it will be the first manufacturer of the product in China. More details....
Stock Symbol: (HKEX: 8058) Share this with colleagues:
This article is available for purchase - please click here for details.
Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today?